You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mTOR

Showing 1 - 25 of 1,004
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dietary Protein Trial in Saint Louis (Dietary protein shake)

Active, not recruiting
  • Dietary Protein
  • Dietary protein shake
  • Saint Louis, Missouri
    Washington University
Jan 29, 2023

IBD Trial in Tanta (Mesalamine, Fenofibrate)

Recruiting
  • Inflammatory Bowel Diseases
  • Tanta, Shebeen El-Kom, Egypt
    Faculty of Medicine, Menoufia University
Mar 11, 2023

Insulin Sensitivity Trial in Copenhagen (other, procedure, drug)

Recruiting
  • Insulin Sensitivity
  • Exercise
  • +3 more
  • Copenhagen, Denmark
    University of Copenhagen
Jun 20, 2022

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022

Aging Trial in Madison (Sirolimus, Everolimus)

Not yet recruiting
  • Aging
  • Madison, Wisconsin
    University of Wisconsin
Jul 17, 2023

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)

Recruiting
  • Muscle Atrophy
  • Age-Related Sarcopenia
  • Rapamune (sirolimus) 1Mg Tablet
  • Unilateral resistance exercise training
  • Derby, United Kingdom
    University of Nottingham School of Medicine
Jun 7, 2022

Focal Cortical Dysplasia, Epilepsy Trial in London (Blood and nasal swab sampling)

Recruiting
  • Focal Cortical Dysplasia
  • Epilepsy
  • Blood and nasal swab sampling
  • London, United Kingdom
    King's College Hospital
Sep 18, 2023

Pulmonary Hypertension Trial in United States (ABI-009, nab-rapamycin, albumin-bound rapamycin)

Active, not recruiting
  • Pulmonary Hypertension
  • ABI-009, nab-rapamycin, albumin-bound rapamycin
  • Tucson, Arizona
  • +5 more
Aug 22, 2022

Atherosclerosis Trial in Saint Louis (Meal)

Recruiting
  • Atherosclerosis
  • Meal
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2022

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • (no location specified)
Mar 2, 2022

Cognitive Impairment, Mild, Alzheimer Trial in San Antonio (Rapamune)

Active, not recruiting
  • Cognitive Impairment, Mild
  • Alzheimer Disease
  • San Antonio, Texas
    UTHSA McDermott Clinical Sciences Building
Feb 3, 2022

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Aging Trial in San Antonio (rapamycin)

Recruiting
  • Aging
  • San Antonio, Texas
  • +1 more
May 17, 2022

Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

Completed
  • Breast Cancer
  • +2 more
  • No intervention, it was a retrospective study.
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 13, 2021

Metastatic Breast Cancer Trial in France (Biopsy)

Completed
  • Metastatic Breast Cancer
  • Biopsy
  • Angers, France
  • +11 more
Sep 19, 2022

Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

Terminated
Has Results
  • Soft-tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 19, 2022

Desmoid Tumor Trial in United States (Sirolimus)

Completed
  • Desmoid Tumor
  • Los Angeles, California
  • +7 more
Jul 5, 2022

IBD Trial (Atorvastatin 80mg, Mesalamine)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • (no location specified)
Oct 14, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Atherosclerosis Trial in Saint Louis (Standard meal, High animal protein meal, High plant protein meal)

Not yet recruiting
  • Atherosclerosis
  • Standard meal
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 12, 2022

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)

Completed
Has Results
  • Epilepsy
  • +2 more
  • New York, New York
    New York University Langone Medical Center
Aug 31, 2021